AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
May 10, 2012
30583_dirs_2012-05-10_f9d02cec-3e1f-4fde-adcb-b66ca043db08.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-05-08
Reporting Person: HERON ELAINE J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-08 | Common Stock | A | 3400 | — | Acquired | 45900 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-08 | Stock Option (right to buy) | $37.46 | A | 8500 | Acquired | 2022-05-07 | Common Stock (8500) | Direct |
Footnotes
F1: Restricted stock units granted on May 8, 2012. Price not applicable.
F2: Options vest 1/4th each on August 8, 2012, November 8, 2012, February 8, 2013 and May 8, 2013.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19